Allergy Diagnostics Market is expected to grow at an 11.3% CAGR from 2022 to 2032 | FMI

[170 Pages Report] According to ESOMAR-certified Future Market Insights’ (FMI’s) research report, the demand for allergy diagnostics has been increasing significantly due to rising incidence of allergic asthma and food allergies across the globe. As per the study, the global allergy diagnostics market is anticipated to grow at around 11.6% CAGR throughout the forecast period from 2021 to 2031.

According to the report, growing incidence of drug allergies especially from penicillin and morphine has fueled the demand for allergy diagnostics across the globe.

The report also states that increasing air pollution and lack of awareness regarding food and drug allergy in emerging and poor countries are encouraging market players towards developing cost effective allergy diagnostics kits.

According to a report published by the World Health Organization, globally around 262 million people are impacted by asthma out of which 461,000 die from asthma.

Rising demand for effective treatment and addressing causes of asthma will aid the overall expansion of the allergy diagnostics market.

Allergy diagnostics market experienced sluggish growth during the COVID-19 pandemic. This is because the pandemic led to suspension of immunological care and diverted the healthcare professional towards treating COVID patients.

In case of patients with severe asthma or other allergic reaction, virtual care and limited visiting methods were employed to restrict the human contact and stop the virus transmission.

Introduction of cost effective at-home food sensitivity and allergy diagnostic will boost the market growth in upcoming years. Such applications will reduce the burden on hospital and laboratories culminating to reduced allergy diagnostic and medical cost.

In the future, the market is anticipated to grow significantly, as majority of diagnostic laboratories and hospitals are inclining towards automated allergy diagnostics for its high effectiveness. Canada and U.S are likely to yield highly opportunistic prospects, contributing towards the overall expansion of the market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4959

“Surge in food allergies cases along with increasing incidence of asthma in children will catapult the demand of allergy diagnostics during the forecast period,” says the FMI analyst.

Competitive Landscape

Allergy diagnostics market is highly competitive market owing to presence of global market players. Market players are employing multiple marketing techniques to expand their global outreach.

Allergy diagnostics market players are focusing towards employing organic and inorganic strategies to expand their global foothold.

Inorganic strategies include strategic merger and acquisition and forming an alliance with regional distributors to strengthen their supply chain channels.

They are also emphasizing towards faster product approvals, product development and patenting.

Prominent players operating in the allergy diagnostics market are:

  • Hitachi Chemical Co. Ltd
  • Thermo Fisher Scientific Inc.
  • Siemens Healthineers
  • Danaher Corporation
  • HOB Biotech Group Co
  • bioMérieux
  • Hycor Biomedical Inc.
  • Stallergenes Greer
  • R-Biopharm AG
  • Lincoln Diagnostics Inc.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4959

Key Takeaways from FMI’s Allergy Diagnostics Market Study

  • The U.S is expected to dominate allergy diagnostics market on the back of rising incidence of skin allergies especially eczema and skin inflammation along with high rate of allergic rhinitis (hay fever) in black American population.
  • Presence of advance healthcare infrastructure, favorable government and insurance policies, and increased per capita income are key allergy diagnostics market drivers in Canada.
  • The U.K. will offer lucrative opportunities owing to increasing awareness regarding asthma and other allergic reactions like atopic eczema and hay fever. High prevalence of allergies will fuel the demand of allergy diagnostics in the country.
  • Increasing per capita income and increasing government and private funding towards spreading asthma awareness will boost the allergy diagnostics market sales in China.
  • India has low per capita income and presence of sub-par healthcare system. High prevalence of myths and stigmatic beliefs regarding asthma is one of the main factors limiting the market growth.

More Insights on the Global Allergy Diagnostics Market

In its latest report, FMI offers an unbiased analysis of the global allergy diagnostics market, providing historical data for the period of 2017-2022 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of product type (fungal allergy diagnostic and neutral lactase enzymes), by allergen type (inhaled allergens, food allergens, and drug allergens), test type (in-vivo allergy tests and in-vitro allergy tests), and end user (diagnostic laboratories, hospitals, and academic research institutes) across North America, Latin America, Europe, East Asia, South Asia, and Middle East and Africa.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports : https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Small Molecule API Market to total US$ 290.76 Billion by 2032; Oncology to comprise Significant Application: FMI

[300 Pages Report] A recently published study by FMI expects the global demand for small molecule API market to increase at a CAGR of 5% during the forecast period between 2022 and 2032, reaching a total of US$ 290.76 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 4.5%.

In-House and outsourcing manufacturing of small molecule API continue to be hot topics in the pharmaceutical sector. The demand for outsource manufacturing in the small molecule market has been on the rise because of increasing production cost and burden management. Subsequently, rising incidence of chronic diseases, besides investment in research and development (R&D) initiatives have been enabling growth.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4591

Over the years, increased use of novel technologies and the emergence of specialty medicines have been leading to a paradigm shift in the industry. Furthermore, smaller volumes of production are projected to witness a surge. The increasing production of the number of products being launched are a result of flexible manufacturing units and robust processes developed to meet the demand.

Key Takeaways from the Market Study

  • China is expected to register 5.5% CAGR during the forecast period
  • Japan to emerge as another important market for small molecule API, registering a CAGR of 5.4%
  • Germany is projected to account for approximately 30% of the global market share.
  • Standard APIs will continue to hold a maximum share of 79.6% in 2022
  • Oncology accounts for 26.6% of the Small Molecule API Market share by therapeutic area.

“API manufacturing has proven to be quite effective in the last few years. Besides this, factors such as increasing incidence of cancer and subsequently rising demand for effective diagnosis and R&D in oncology therapeutic will fuel the demand for small molecule oncology therapy.” says an analyst at FMI. 

Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-4591

Market Competition

Key players in the Small Molecule API market are Pfizer Inc., Johnson Matthey, Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., Sanofi S.A., Novartis AG, Bristol-Myers Squibb, Boehringer Ingelheim GmbH, GlaxoSmithKline PLC, GILEAD Science Inc., Albany Molecular Research Inc., AstraZeneca, Merck & Co, Inc., BASF SE, Teva Pharmaceuticals, and Hoffmann-La Roche Ltd.

  • In March 2021, U.S. Food and Drug Administration (FDA) has accepted New Drug Application for gefapixant, an orally administered for the Molecule Type of refractory chronic cough (RCC) in adults.
  • In March 2022, Sumitomo Chemical Co., Ltd. announced its investment to build a new manufacturing facility in Japan to meet the surge in demand for high-quality small molecule APIs and intermediates.

More Insights Available

FMI, in its new offering, presents an unbiased analysis of the global small molecule API market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Molecule Type (Standard API, HPAPI), Production (Captive/In-House, Out Source), Application (Clinical, Commercial), Therapeutic Area & Region across seven major regions (North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa).

Table of Content
1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

Get Detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-4591

Key Segments Profiled in the Small Molecule API Market Industry Survey

By Molecule Type:

  • Standard API
  • HPAPI

By Production:

  • Captive/In-House
  • Outsourced

By Application:

  • Clinical
  • Commercial

By Therapeutic Area:

  • Cardiovascular Diseases
  • Respiratory Disorders
  • Infectious Diseases
  • Metabolic Disorders
  • Oncology
  • Immunology
  • Neurology
  • Urology
  • Dermatology
  • Ophthalmology
  • General Health
  • Others

Have a Look at Related Research Reports of Healthcare

RNA-Targeted Small Molecules Market Technlogy : According to the latest research by Future Market Insights, RNA-Targeted Small Molecules market is set to witness a 6.6% growth during the year 2021-2031.

Small-Molecule Injectable Market Size : The global Small-molecule Injectable Market was valued at US$ 52.7 Bn in 2020 and is expected to reach US$ 112.9 Bn by 2031

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Spinal Cord Stimulators Market is expected to grow at over a CAGR of 7.5% during the forecast period (2022-2032).

[274 Pages Report] In terms of value, an impressive 6.4% CAGR is estimated for the global spinal cord stimulators market by a report of Future Market Insights (FMI). In 2017, the market will account for nearly US$ 2,000 Mn in revenues; by 2027 this number is estimated to reach US$ 3,568.2 Mn. Growth of the market is primarily attributed to under penetration of potential market.

Introduction of affordable devices would pave huge opportunities for the global spinal cord stimulators market across developing economies. Customized spinal cord stimulators as per the requirements of an individual is expected to offer higher growth potential for leading market players. Specialists in healthcare settings are more likely to prescribe devices that are smaller in size, owing to their easy implantation and less painful surgical procedure.

Request Sample @– https://www.futuremarketinsights.com/reports/sample/rep-gb-2030

Spinal Cord Stimulators Market

Spinal Cord Stimulators’ Ability of Reducing Opioid Analgesics Addiction to Drive the Market Growth

Majority of patients with chronic pain are increasingly depending upon opioid analgesics; however spinal cord stimulators is capable of reducing this addiction to a great extent. Entry of additional competitors in the market is expected to increase awareness about effectiveness of spinal cord stimulators. Spinal cord stimulators are comparatively more cost-effective than conventional medical management (CMM). Leading companies in the market are taking initiatives in improving technology for spinal cord stimulators. The aforementioned factors are estimated to drive growth of the global spinal cord stimulators market.

However, spinal cord stimulators have little access to evidence-based data in order to confirm effectiveness of these devices for management of chronic pain. Clinical validation of spinal cord stimulation is based on observational data, instead of verified data. This had led several private insurance companies to refuse reimbursement of costs, which in turn is impeding the market growth. In addition, complications associated with spinal cord stimulators, such as paresthesia- characterised by burning sensation, is further expected to restrain growth of the global spinal cord stimulators market.

Rechargeable Spinal Cord Stimulators will Remain Sought-After Product in the Market

In terms of value, rechargeable spinal cord stimulators are expected to remain sought-after product in the market. Revenues amassed from sales of rechargeable spinal cord stimulators are expected to reach US$ 2,530.4 Mn by 2027-end. In addition, sales of non-rechargeable spinal cord stimulators are anticipated to expand at 4.6% CAGR through 2027. Factors such as low battery life, and requirement of surgery for replacement of battery are restricting adoption of non-rechargeable spinal cord stimulators across the globe.

Application of spinal cord stimulators will remain highest in failed back surgery syndrome (FBSS), with sales estimated to surpass US$ 1,000 Mn in 2017. In addition, complex regional pain syndrome (CRPS) is projected to be the second-fastest growing application of spinal cord stimulators in the market. In terms of value, sales of spinal cord stimulators in CRPS are estimated to register 5.8% CAGR through 2027.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2030

Adoption of Spinal Cord Stimulators to Witness Fastest Growth in Ambulatory Surgical Centres

Although hospitals will continue to be largest end-users of spinal cord stimulators, adoption will witness fastest growth in ambulatory surgical centres. Sales of spinal cord stimulators in hospitals are estimated to account for revenues worth US$ 627.9 Mn in 2017. Demand for spinal cord stimulators in ambulatory surgical centres is projected to exhibit 6.8% CAGR through 2027. In contrast, demand for spinal cord stimulators in clinics will remain sluggish in the market.

North America will continue to remain dominant in the global spinal cord stimulators market, with sales estimated to reach nearly US$ 3,000 Mn in revenues by 2027-end. Western Europe will remain the second-largest market for spinal cord stimulators, expanding at 6.1% CAGR through 2027. In addition, markets in Eastern Europe and Japan are estimated to exhibit parallel expansion at 6% CAGR through 2027.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2030

Key market players identified in FMI’s report include

  • Boston Scientific Corp.
  • Medtronic Private Limited Company
  • St Jude Medical LLC
  • Nevro Corp
  • Nuvectra Corporation
  • Stimwave
  • Saluda Medical PTY Limited.

Spinal Cord Stimulators Market Taxonomy Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • MEA
  • Japan

End User

  • Hospitals
  • Ambulatory Surgical Units
  • Clinics

Application

  • Failed Back Surgery Syndrome
  • Complex Regional Pain Syndrome
  • Ischemic Limb Pain
  • Others

Product Type

  • Rechargeable
  • Non-Rechargeable

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Obesity Management Market is expected to grow with a CAGR of 5.1%, from USD 828.71 Mn in 2022 to USD 1362.80 Mn by 2032 | FMI

[324 Pages Report] Globally, more than 1 billion individuals are overweight or obese and the numbers continue rising. This high prevalence of obesity will drive demand for obesity management products and services in the long term.

According to the World Health Organization (WHO), approximately 1.9 billion adults were overweight and 650 million adults were obese. Whereas 38.3 million children under 5 years of age were either overweight or obese in 2019. One in three adults in North America is obese. In the U.S., 80 million adults and 12.7 million children suffer from obesity.

Obesity is a prominent community health problem in many parts of the world. It is associated with numerous health disorders including gallbladder disease, heart disease, diabetes, stroke, hypertension, and fatty liver disease in addition to some cancers. According to a recent Future Market Insights (FMI) report, the market is set to surpass US$ 1.2 Bn by the end of the forecast period in 2031, with a CAGR of over 5%.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-587

Furthermore, there has been an increase in the per capita healthcare expenditure, especially in developed countries, with better reimbursement policies. People are now inclined towards out-of-pocket expenditure healthcare. Personal health, grooming, and concerns over social discrimination are leading people to take obesity management consultations.

However, the unprecedented pandemic crisis has had a significant impact on the obesity management market due to a slump of patient footfall in hospitals and clinics. Preference is now being given to the treatment of COVID-19 patients, limiting resources for anti-obesity consultations and related drugs or surgeries.

Also, there has been a halt in clinical trials for weight management drugs. However, with the availability and commencement of the COVID-19 vaccination, the clinical trials are resuming and are anticipated to pick up pace during the forecast period. Also, the adoption of telehealth and in developing countries is likely to bode well for the future of the market in the long term.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-587

Key Takeaways from Obesity Management Market Study

  • Bupropion and Naltrexone will reflect register faster growth at a CAGR of 8.4%, owing to an increase in the preference for combination therapy in weight management.
  • Gastric sleeve surgery will account for over 40% of the market throughout the forecast period owing to benefits of simplicity and time-efficiency.
  • The U.S. will lead the North America market with a share of over 64% in 2021, driven by continuing diet and lifestyle issues prevalent in the country.
  • Germany followed by Russia are leading markets in Europe, reflecting CAGR of over 6% through the end of 2031, driven by improvements in public health programs.
  • Japan dominates the East Asia market, accounting for 49% value share in 2021, with government awareness programs contributing to growth.

“The rapidly increasing obesity cases and the resultant chronic diseases have triggered concern among patients and healthcare professionals. The COVI-19 crisis has alarmed people, as overweight people are at higher risk of acquiring SARS-COV2. This consciousness may help in encouraging obesity management uptake through 2021 and beyond,” says the FMI analyst.

Key Participant Insights

Prominent players in the Obesity Management Market are focusing on collaborations, mergers & acquisitions for global expansion and enhanced opportunities focused on emerging economies thereby, enhancing their market presence.

The key market players covered by FMI include GlaxoSmithKline Plc., VIVUS, Inc., Novo Nordisk A/S, Currax Pharmaceuticals LLC, Cheplapharm Arzneimittel GmbH, Bausch Health Companies Inc., and Takeda Pharmaceuticals, Inc.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-587

Obesity Management Market by Category

By Drug Type:

  • Bupropion and Naltrexone
  • Orlistat
  • Lorcaserin
  • Phentermine and Topiramate
  • Liraglutide

By Surgery Type:

  • Gastric Bypass Surgery
  • Adjustable Gastric Banding Surgery
  • Gastric Sleeve Surgery
  • Duodenal Switch Surgery
  • Others

By Distribution Channel:

  • Hospitals Pharmacies
  • Retail Pharmacies
  • E-commerce

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Smart Insulin Pens Market is expected to post massive gains, expanding at a staggering double digit CAGR through 2031

[108 Pages Report] ESOMAR-certified consulting firm Future Market Insights (FMI) projects the global smart insulin pens market is likely to surpass the billion dollar mark by 2021, expanding at a positive CAGR, as per a newly published research report. A stupendous double digit growth rate has been predicted for the market in the long-run. Growing preference for non-invasive treatment and the ever widening diabetes burden are likely to steer the market in a forward direction.

According to FMI’s report, the market posted significant gains in the past, with Bluetooth smart insulin pens generating over 30% of the revenue share in 2017. Also, according to the International Diabetes Federation, presently, just under half a billion people are living with diabetes worldwide, and their number is projected to increase by 25% in 2030, and 51% by 2045 respectively.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1827

Manufacturers, therefore, are leveraging these trends to introduce novel and innovative product lines, enabling them to secure a firm footing in the market. In November 2020, for instance, Medtronic launched its InPenTM smart insulin device equipped with real-time GuardianTM Connect CGM Data- the first smart insulin pen for diabetics on multiple daily injections. Recently, in April 2021, BioCorp and Roche Diabetes Care launched the Mallya smart insulin pen device in France.

Key Takeaways from FMI’s Smart Insulin Pens Market Report

  • By connectivity, Bluetooth connected smart insulin pens to account for over half of the revenue share by 2031
  • By indication, type 2 diabetes treatment to account for the bulk of smart insulin pens deployment
  • Retail pharmacies were the primary distribution channels for smart insulin pens, e-commerce sales spiking rapidly
  • US to experience credible growth amid increasing approval rates for new diabetes management devices
  • Growing preference for needle-free insulin injections to widen adoption across the UK
  • Germany & France to experience increased collaborations between key manufacturers in the long-run
  • Large concentration of regional level manufacturers to pivot growth across India and China

Smart Insulin Pens Market – Key questions answered in the report

  • What trends are in store for the smart insulin pens market growth?
  • According to FMI, the global smart insulin pens market is likely to register a multi-billion dollar valuation in the short and long-run forecasts, attributed to a general increase in the global diabetic population pool and the consequent increase in hospital workload. Demand for Bluetooth connected smart insulin pens is expected to remain especially high
  • Which is the most promising smart insulin pens market?
  • As per FMI’s analysis, demand for smart insulin pens are expected to remain high across the US market, attributed to unceasing efforts by the government to eradicate the diabetes epidemic by virtue of extensive advertising campaigns. Additionally, India and China are expected to emerge as the dominant markets in the Asia-Pacific region, characterized by the presence of numerous regional level manufacturers

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1827

Which prominent players operate in the global smart insulin pens market?

  • Digital Medics Pty Ltd.,
  • Emperra GmbH e-Health Technologies,
  • Companion Medical Inc.,
  • Sanofi Aventis LLC,
  • Novo Nordisk A/S,
  • Eli Lily and Company,
  • Companion Medical,
  • Diabnext,
  • Jiangsu Delfu Medical Device Co. Ltd.,
  • DIAMESCO Co Ltd.,
  • Patients Pending Ltd (Bigfoot Biomedical Inc.),
  • BERLIN-CHEMIE

are some major smart insulin pens manufacturers profiled in FMI’s report

Competitive Landscape

Major insulin pens manufacturers are effectively leveraging major expansion strategies, ranging from new product launches and R&D to collaborating with existing manufacturers or outright/partial acquisition of key market players. A major emphasis is being laid on incorporating virtual technological advancements to enhance diabetes management.

In February 2021, Novo Nordisk and the University of Toronto announced a CAD 40 million investment deal to establish the Novo Nordisk Network for Healthy Populations. This network will focus on new approaches to address diabetes and aid in chronic disease prevention. This will likely help broaden smart insulin pens development.

Companies are also focusing on providing advanced software platforms, such as Digital Medics’ DiabetesPlus DataSync Software. This platform enables users to download insulin and glucose data directly from the device. Key features include downloading insulin data from the insulin pen, glucose levels from the glucose meter and synchronization of data on the Cloud for use with mobile devices.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1827

According to FMI’s report, the following insulin pens manufacturers currently operate in the global market:

  • Digital Medics Pty Ltd.
  • Emperra GmbH e-Health Technologies
  • Companion Medical Inc.
  • Sanofi Aventis LLC
  • Novo Nordisk A/S
  • Eli Lily and Company
  • Diabnext
  • Jiangsu Delfu Medical Device Co. Ltd.
  • DIAMESCO Co Ltd.
  • Patients Pending Ltd (Bigfoot Biomedical Inc.)
  • BERLIN-CHEMIE

Smart Insulin Pens Market – Key Segments Covered

Indication

  • Diabetes Type I
  • Diabetes Type II

Connectivity

  • Bluetooth Connected
  • USB Connected

Distribution Channel

  • Clinics & Ambulatory Surgical Centers
  • E-Commerce
  • Retail Pharmacies

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Intravenous Solution Compounders Market Size, Share, CAGR & Forecast Report for 2028

Intravenous Solution Compounders Market Overview

Intravenous medication is one of the crucial aspects of hospital and pharmacy, and preparation of these requires utter precision as the patient’s wellbeing is directly affected by the compounded preparations. Increasing intravenous preparations use in hospitals is increasing the demand for intravenous solution compounders.

Intravenous solution compounders are choice of instrument in compounding of the intravenous solution or parenteral drug preparation. Intravenous solution compounders are the automated compounding and pumping devices which allows preparation of sterile solution according to the specific requirement in the pharmacy and hospitals. The intravenous solution compounders consists of the base solution reservoir, diluents set which offers increased feasibility in compounding the solution.

Intravenous solution compounders performs the procedure in two step process or in one step process, where micro and macro solutions can be processed in one step or in two-steps, one step process eliminates the chance of possible contamination in intravenous solution compounders. The process of intravenous solution compounders is based on gravimetric principal or volumetric principal.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7532

Intravenous Solution Compounders Market: Drivers and Restraints

Intravenous Solution Compounders are mainly utilized to reduce the risk of contamination while preparing the sterile preparation. The rising awareness about the safety of patient and complexity in the compounding of the intravenous solution is anticipated to propel the market growth for intravenous solution compounders.

The major challenges in compounding intravenous solution is complexity in verification of solution prepared and process followed is technically very intricate. The elimination of verification and easy technicality is anticipated to drive the market for intravenous solution compounders. The major sector arising in utilization of the intravenous solution compounders is total parenteral nutrition coupled with Increasing number of patient specific dose is anticipated to impel the market demand for intravenous solution compounders.

The added advantages of intravenous solution compounders in reducing the risk of injectables medication errors specifically in cancer chemotherapy preparation is anticipated to fuel the market for intravenous solution compounders market. However, high coast associated with intravenous solution compounders and requirements of particular dispensing on daily basis is anticipate the restraint the growth of the intravenous solution compounders market.

Intravenous Solution Compounders Market: Overview

The global Intravenous Solution Compounders market is witnessing a steady growth due to increasing awareness among the end user in maintaining high standards and precaution methods while preparing the intravenous solutions.

The demand for demand for intravenous compounders is mainly arising from developed countries due to well-developed healthcare infrastructure and high healthcare standards. The manufacturers in the intravenous solution compounders is focused on continuous research and development to increase the effectives of the intravenous solution compounders device.

The development of countertop devices with minimal technical difficulty is offering the edge for countertop intravenous solution compounders device in the market. The advantage of intravenous solution compounders in compounding robotics and enlarge intravenous preparation coupled with automation is anticipated to offer manufactures a niche market to target.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7532

Intravenous Solution Compounders Market: Region-Wise Overview

The global Intravenous Solution Compounders market is segmented into the following regions – North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding China & Japan, China, Japan and the Middle East & Africa. North America is the dominant regional market for Intravenous Solution Compounders due to rising awareness for the risk associated with manual compounding of the intravenous solutions in the region. In North America, the U.S. is the dominating market due to high healthcare standards and regulatory guiding for compounding of sterile preparations.

Europe Intravenous Solution Compounders market is anticipated to grow substantially due to rising initiatives by the government to minimize the risk of contamination and errors in sterile compounding. APAC is a fast-growing regional market for Intravenous Solution Compounders due to increasing demand for standards compounding instruments and raising awareness for parenteral solutions safety in the countries like India and china. Growth in the Latin America and the Middle East and Africa is growing steadily due to demand for total parenteral nutrition.

Intravenous Solution Compounders Market: Key Participants

Examples of some of the key participants in the Intravenous Solution Compounders market are ARxIUM, Baxa Corporation., ICU Medical Inc., B.Braun Medical Inc, Baxter Healthcare., Grifols., Hospira Inc and The Matrix Company Among others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-7532
The report covers exhaust analysis on
  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

X-Ray Aprons Market Size & Share | Global Industry Report for 2028

X-Ray Aprons Market Overview

X-ray aprons are also known as lead aprons or leaded aprons used for protection against harmful radiations. It is a type of protective clothing that acts as the radiation shield. Lead X-ray aprons are used to reduce exposure of radiation to both patient and personnel.

X-ray aprons are made up of thin rubber sheet at the exterior. X-ray aprons are used along with lead gloves and lead glasses. The main purpose of using X-ray apron is to minimize the exposure of harmful X-ray to vital organs. Prolonged exposure to X-ray has been linked to increasing chances of developing cancer. X-ray aprons protect vital organs from harmful radiations exposed during medical imaging processes such as radiography, computed tomography, fluoroscopy and others.

X-ray aprons also help to protect reproductive organs. Protective reproductive organ is important as radiation may cause changes in the DNA of egg cell and sperm which leads to genetic defects in the offspring of the patients. According to researchers, the thyroid gland is most vulnerable to X-rays. Care should be taken to protect or cover thyroid gland using X-ray aprons or thyroid collars during dental radiographs.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-7309

X-Ray Aprons Market: Drivers & Restraints 

Increase in the number of medical imaging processes drives the global X-ray aprons market. Other factors such as rise in geriatric population and increase in awareness among the people also expanded the growth of global X-ray aprons market in the stated forecast period. Increase in the number of diagnostic imaging centers in developed and developing countries also boost the market growth of X-ray aprons.

Technological advancement and increasing prevalence of diseases that requires medical imaging also escalate the market growth of X-ray aprons. High cost and lack of reimbursement policies restrain the growth of X-ray aprons in the stated forecast period. Heaviness associated with the lead X-ray aprons has shown the detrimental effect on the health of the wearer, particularly spinal injuries also decline the growth of X-ray aprons market.

X-Ray Aprons Market: Overview

There are different types of X-ray aprons available in the market with various modifications. The regular lead X-ray aprons are made up of 100% lead and are the heaviest among all other types. The lead composite X-ray aprons are made up of lead and other light weighted metals such as barium and tin, making it lighter than the regular lead X-ray aprons.

Lead-free X-ray aprons are made up of non-lead attenuated metals. They are the lightest and provide complete protection, along with being These aprons are the lightest ones environmental friendly.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-7309

X-Ray Aprons Market: Regional Outlook

X-ray aprons market is segmented on the basis of eight regions into North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan and China (APECJ), Japan, China and Middle East & Africa (MEA). North America is dominating the overall X-ray aprons market throughout the forecast period. The presence of better healthcare facilities, increase in the number of diagnostic centers and high patient awareness level are some of the leading factors accounting for the maximum market share in these regions.

This is followed by Europe, due to better healthcare infrastructure and increase in the number of diagnostic procedures. In developing regions such as Asia-Pacific, X-ray aprons market is expected to grow at the fastest rate during the forecast period due to improving healthcare infrastructure and increasing prevalence of chronic diseases. Middle East and African region is expected  to grow at moderate rate due to poor healthcare facilities and lack of awareness among the patients.

X-Ray Aprons Market: Key players

Some of the leading players operating in the X-ray aprons market are:  Lite Tech, Inc., Barrier Technologies, Wolf X-Ray, Shielding International, Inc., Biodex Medical Systems, Inc., Rego X-ray GmbH, Techno-Aide, Inc., and others.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-7309

X-Ray Aprons Market: Segmentation

The global market for X-ray aprons is segmented on the basis of material type, end users and geography.

Based on the material type, X-ray aprons market is segmented into:

  • Lead free X-ray aprons
  • Light weight lead composite X ray aprons
  • Lead X ray aprons

Based on end-user, X-ray aprons market is segmented into:

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Automated Microbial Detection Systems Market Insights By Type, Industry, Application & End-User | FMI

Market Outlook

A number of infectious diseases and the increasing number of resistant strains of microorganisms lead to the development of microbial detection kits. However these traditional methods of culturing and then identification is time consuming. Automated microbial detection systems is one solution for this problem.

Using these systems the detection process of microorganisms can be done within a few minutes of culturing and the results could be available within a couple of hours. Automated microbial detection systems are automated tools used for the detection of key contaminant microorganisms.

These methods allow for preventive controls and faster testing. The results could be obtained within a few hours using the automated microbial detection systems, when compared to the traditional culturing methods.

A number of large and small players provide automated microbial detection systems. Some of them include Thermo Fisher Scientific, Lonza, Pall Corporation, MediRay, BioMeriux and MIDI Inc.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6955

Market Dynamics of Automated Microbial Detection Systems Market

A number of factors drive the growth of the automated microbial detection systems market. Some of these include the increase in incidence of infectious diseases that are coupled with epidemic and pandemic events that occur every year.

Increasing food safety concerns is another factor that drives the growth of the automated microbial detection system market. Technology advancements and government initiatives to aid the development of the market further.

However, high cost of automated microbial detection systems and complex regulatory framework slightly hinder the growth of the automated microbial detection systems market.

Genotypic Methods are Popularizing

When genotypic methods are applied for the identification of microorganisms it results in specie-specific fingerprints. The genotypic methods of automated microbial detection systems are fast and reliable.

New genotypic methods include the use of microchips coated with an array of oligonucleotides that allows rapid identification, by the determination of patterns or sequences that are specific to an organism.

DNA sequencing and biochemical sequencing coupled with fluorescent analysis of the product is also being developed for automation.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6955

Automated Microbial Detection Systems in Diagnostic Laboratories

Diagnostic laboratories culture different kinds of samples such as blood and urine for diagnosis of infectious diseases. With the traditional method of culturing and testing the results could take days and the patient may be in distress until then. There is a need to reduce the time required for the detection process. This can be achieved by the use of automated microbial detection systems.

Regional Market Outlook

Although North America will continue to hold the largest share in the automated microbial detection systems market, Asia-Pacific is expected to grow with the largest CAGR.  The continued focus of the major player towards emerging and Asian countries as well as due to the support of the government in these region leads to development of the automated microbial detection systems market in the region.

Competition Outlook

Automated Microbial Detection Systems are expensive devices. Thus the Automated Microbial Detection System Market is dominated by large players like Thermo Fisher Scientific, Becton Dickinson, Merck Millipore and Lonza. The other small players include Biomerieux, MIDI Inc and MediRay.

Small-Scale Manufacturers/Providers Medium-Scale Manufacturers/Providers Large-Scale Manufacturers/Providers
  • MediRay
  • Micro Identification Technologies
  • MIDI, Inc.
  • Trivitron Healthcare
  • Biomerieux
  • Thermo Fisher Scientific
  • VWR (Avantor)
  • Becton Dickinson
  • Charles River
  • Merck Millipore
  • Lonza
  • Pall Corporation

Research Methodology

FMI utilizes a triangulation methodology that is primarily based on experimental techniques such as patient-level data, number of procedures and capital equipment install base to obtain precise market estimations and insights on various medical devices and medical technology.

Bottom-up approach is always used to obtain insightful data for the specific country/regions. The country specific data is again analysed to derive data at a global level. This methodology ensures high quality and accuracy of information.

Secondary research is used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product offerings, usage pattern as per disease indications, product installed base in target healthcare facilities, life span of a device, reimbursement scenario, adoption rate and future impact of new technologies.

Each piece of information is eventually analysed during the entire research project which builds a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, and supply-side providers of medical devices who provide valuable insights on trends, key treatment patterns, adoption rate, and purchasing pattern, technological development of medical devices, patient education, effectiveness of manufacturers and important strategies, pricing and competitive dynamics.

Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analysed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

On the other hand, we also analyse various companies annual reports, investor presentations, SEC filings, 10k reports and press release operating in this market segment to fetch substantial information about the market size, trends, opportunity, drivers, restraints and to analyse key players and their market shares. Key companies are segmented at Tier level based on their revenues, product portfolio and presence.

Please note that these are the partial steps that are being followed while developing the market size. Besides this, forecasting will be done based on our internal proprietary model which also uses different macro-economic factors such as per capita healthcare expenditure, disposable income, industry based demand driving factors impacting the market and its forecast trends apart from disease related factors.

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-6955

Key data points covered in report

The report covers exhaustive analysis on:

  • Automated Microbial Detection Systems Market by technology, end user and region
  • Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by technology, end use segments and country
  • Automated Microbial Detection Systems Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Automated Microbial Detection Systems Market Size & Forecast 2018-2028
  • Automated Microbial Detection Systems Market Trends/Issues/Challenges
  • Competition & Companies involved

Market Segmentation

By Technology

  • Phenotypic Methods
  • Genotypic Methods

By End user

  • Pharmaceutical and Biotechnology Industry
  • Food & Beverages Industries
  • Water & Environment Industries
  • Diagnostic Laboratories
  • Blood Banks
  • Hospitals
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Vascular Testing Devices Market Size & Share | Industry Trends Analysis Report for 2028

Vascular Testing Devices Market Overview

Vascular disease is of two type viz. peripheral artery disease (PAD) and chronic venous insufficiency (CVI). Vascular disease can be life-threatening due to incorrect and delay diagnosis. Vascular testing devices encompass a broad range of equipment and expertise for proof of principle.

Vascular testing is also known as non-invasive vascular testing in which various technology based devices are utilized to evaluate the blood vessels. The evaluation and testing of the blood vessels can be done at the rest time or at the time of the exercise. Vascular testing is generally painless and determine the disease location and severity.

Vascular testing devices are comes with the advanced features such as digital dashboard and online interface with the remotely located facility centers. These devices also come with the specifications such as LAN/WAN and DICOM/PACS compatibility.

The increasing incidence of death and other complications due to stroke and myocardial infarction amongst those with silent asymptomatic peripheral vascular disease is the key growth factor boost the use of vascular testing devices for diagnosis purpose.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6884

Vascular Testing Devices Market: Drivers & Restraints

The global vascular testing devices market is expected to register a significant CAGR over a forecast period. The increasing prevalence of vascular diseases and disorders, lifestyle diseases is the key factor anticipated to propel the demand for vascular testing devices and drives the growth of the global vascular testing devices market.

The technically advanced vascular testing devices allows great access to vascular disease testing in particularly non-interventional settings, which helps to diagnose more patients with disease before disease progresses to a potentially critical stage. The availability of portable and easily operable testing devices for vascular diseases is also expected to be the major factor drives the growth of the global vascular testing devices market over the forecast period.

The vascular devices also work on the telemedicine technology and send test data to a remotely located specialist for the online interpretation which anticipated to surge the demand for vascular testing devices over the long run.

However, the lack of expertise and physicians to operate vascular testing devices and to interpret the test data may restrain the growth of the global vascular testing devices market over the forecast period. The higher cost of set up of the vascular testing lab and devices may hamper the demand of vascular testing devices and restrain the growth of the global vascular testing devices market over the long run.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-6884

Vascular Testing Devices Market: Region-wise Outlook

On the basis of regional presence, the global vascular testing devices market is segmented into eight key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding China and Japan, China, Japan, and Middle East & Africa. Currently, North America is contributing the leading share to the global vascular testing devices market in terms of value and anticipated to register a significant growth over a forecast period due to developed medical infrastructure and increasing spending on high end diagnostic technologies.

Europe region also contribute significant amount of revenue share to the market followed by North America. APAC region is the most lucrative market for the vascular testing devices due to the increasing prevalence of the vascular diseases in the region and expected to show a robust growth to the global vascular testing devices market. Overall, the global vascular testing devices market is expected to show significant growth over a forecast period.

The report covers exhaustive analysis on

  • Vascular testing devices market segments
  • Vascular testing devices market dynamics
  • Historical actual market size, 2013 – 2017
  • Vascular testing devices market size & forecast 2018 to 2028
  • Vascular testing devices current trends/issues/challenges
  • Competition & companies involved
  • Vascular testing devices market drivers and restraints

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-6884

Vascular Testing Devices Market: Segmentation

The global vascular testing devices market is segmented on the basis of modality type, technique type, test type and end user.

On the basis of modality type, the global vascular testing devices market is segmented into:

  • Portable
  • Standalone

On the basis of technique type, the global vascular testing devices market is segmented into:

  • Arterial Doppler
  • Pulse Volume (PV) Arterial
  • Photoplethysmography
  • Color or Black And White Arterial Duplex
  • MRA
  • CT and MR Angiography
  • Standard Invasive Angiography

On the basis of test type, the global vascular testing devices market is segmented into:

  • Toe pressure
  • Transcutaneous oxygen (tcpO2 / TCOM)
  • Pulse volume recording
  • Segmental pressures
  • Skin perfusion pressure
  • Heat-controlled laser Doppler
  • Others

On the basis of end user, the global vascular testing devices market is segmented into:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Specialty Clinics
  • Mobile Testing Centers
  • Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Transcutaneous Bilirubinometers Market Size & Industry Trends Report for 2027

Transcutaneous Bilirubinometers Market: Overview

Transcutaneous Bilirubinometers is a non-invasive method and is based on the principle of multi wavelength spectral reflectance from the bilirubin staining in the skin. The accuracy of the instrument may be affected by variation of skin pigmentation and its thickness.

There are two treatment options for treating hyperbilirubinemia one through phototherapy and other through pharmacological treatment. Phototherapy is further sub dived as intensive, conventional and exchange transfusion. Pharmacological treatment is divided as phenobarbitone, intravenous immunoglobulins (IVIG), and metalloporphyrins and follow up remedies.

Transcutaneous Bilirubinometers Market Overview

Hyperbilirubinemia or jaundice is a multifactorial condition in new-borns with several symptoms. Physiological jaundice is visible but there is also pathological jaundice which is not visible whose prevalence is more in few countries. When the total bilirubin level rise above 95th percentile for a given age group, it is considered as hyperbilirubinemia.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5968

While bilirubin in normal level act as an antioxidant to the biological system, the presence of it towards the higher site may lead of the central nervous system damage leading to the neurological and behavioural impairment. There are several types of bilirubinaemia which are pathological, physiological, and haemolytic and jaundice due to breastfeeding.

Haemolytic bilirubinaemia is further subdivided into ABO blood group incompatibility, Rh factor incompatibility and jaundice associated with Glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Transcutaneous Bilirubinometers Market: Drivers and Restraints

According to the National Neonatal-Perinatal Database (NNPD), the incidence of hyperbilirubinemia is 3.3% while the morbidity occurrence due to it is 22.1%. In neonates, the pale yellow color first starts from the face and the proceeds to the body and the extremities. The incidence of jaundice is more in the low and middle income countries.

For instance out of the 1.1 million babies that are diagnosed for jaundice majority of them are in the sub-Saharan Africa and South Asia. Moreover, the launch of upgraded products and technology towards the detection of bilirubin level through a non-invasive way is being adopted by various industry players.

Transcutaneous Bilirubinometers Market: Region-wise Outlook

In terms of geography, transcutaneous Bilirubinometers market has been divided into seven regions including North- America, Eastern Europe, Western Europe, and Asia- Pacific excluding Japan, Japan Middle-East & Africa and Latin America. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region.

North region. The countries in North America such as the U.S and Canada are taking various initiatives such as the launch of the “Calgary jaundice program” to decrease the number of hospital readmissions for pediatric jaundice. The screening program which was launched around 2007 uses light reflection to determine the level of jaundice in new-borns. Since the launch of this program hospital readmissions for pediatric jaundice has dropped by approximately 30%.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5968

Transcutaneous Bilirubinometers Market: Key Market Participants

Some of the transcutaneous bilirubinometers market participants are Aegis Medical Innovations, Delta Medical International, Drägerwerk AG, Beijing M&B Electronic Instruments Co. Ltd, Micro Lab, Natus Medical, Philips Healthcare, Refine Medical Technology, Reichert Technologies and Xuzhou Kejian Hi-tech.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/5968

Transcutaneous Bilirubinometers Market: Segmentation

On the basis of product type the transcutaneous bilirubinometers market can be segment as:

  • Benchtop
  • Portables

On the basis of end user the transcutaneous bilirubinometers market can be segment as:

  • Hospitals
  • Pediatric and Neonatal Intensive Care Units
  • Nursing Homes
  • Home/Outpatient Settings Private research laboratory

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs